Resilience (also known as National Resilience) is a company that provides biomanufacturing and technology solutions. It offers cell and gene therapy, biologics, vaccines, and nucleic acids. The company also develops Auto-T, a manufacturing and assay platform for lentiviral vectors (LVV)-based autologous cell therapies for clinical trials; and SnapLVV, a tool for shelf process to get cell therapy for human studies.